Aurora Cannabis Inc. shares fell 9 per cent in post-market trading as it became the latest pot company to miss estimates.

Aurora reported quarterly net revenue of $75.2 million (US$56.8 million), below the average analyst estimate of $90.6 million. Sales into the Canadian recreational market tumbled 33 per cent to $30 million.

The company’s adjusted loss before interest, taxes, depreciation and amortization was $39.7 million, wider than the expected $20.8 million. It also appeared to walk back its statement last quarter that it “continues to track toward positive adjusted Ebitda,” citing “near-term challenges to achieving positive adjusted Ebitda.”

Aurora said it has ceased construction at its Aurora Nordic 2 facility in Denmark, which will save approximately $80 million over the next year. The company also reached an agreement with investors holding about $155 million of its March 2020 convertible debentures to convert early at a lower price.

Earlier Thursday, Canopy Growth Corp. reported revenue that missed the lowest analyst estimate amid a large restructuring charge, sending its shares to the lowest since 2017. Investors are growing increasingly impatient with cannabis companies that don’t show a clear path to profitability.

Cannabis Canada is BNN Bloomberg’s in-depth series exploring the stunning formation of the entirely new – and controversial – Canadian recreational marijuana industry. Read more from the special series here and subscribe to our Cannabis Canada newsletter to have the latest marijuana news delivered directly to your inbox every day.